Seattle, Aug 2, 2021 (GLOBE NEWSWIRE) – AGC Biologics, one of the world’s leading Biopharmaceutical Contract Progression and Production Organizations (CDMO), has announced a new appointment to oversee strategic progression and operational excellence in production of clinical and advertising biologics on their site in Seattle, Washington. Beginning August 2, 2021, Kevin Ingham will join the Seattle team as General Manager / Site Manager. Ingham has a successful track record of over 18 years of leadership in the biotech and production industry, adding roles with the expansion of day-to-day jobs at Roche and Genentech. In his new role, Ingham will continue to expand the site, while largely marrying colleagues in AGC Biologics’ global paint services network to bring new biopharmaceuticals to market. “We are very pleased that Mr. Ingham is joining us as General Manager / Site Manager for the Seattle site. He brings great delight and leadership skills, ”said J. D. Mowery, executive vice president of US operations for AGC Biologics. “I have no doubt that Mr. Ingham will take the Seattle site to new heights in the months and years to come. ” About AGC Biologics: AGC Biologics is one of the world’s leading Biopharmaceutical Contract Progression and Production Organizations (CDMOs) with a strong commitment to delivering the highest point of service as we paint look by look with our consumers and spouses, in each and every step of the process. way. We supply world-class progression and manufacturing of microbial and mammalian healing proteins, plasmid DNA (pDNA), viral vectors and genetically modified cells. Our global network paints span the United States, Europe, and Asia, with cGMP-compliant services in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milano, Italy; and Chiba, Japan, and lately we employ more than 1,900 people worldwide. Our commitment to uninterrupted innovation fosters technical creativity to solve the most complex challenges of our clients, adding specialization in streamlined projects and rare diseases. AGC Biologics is the preferred spouse. To be more informed, stop over at www. agcbio. com.
